This resulted in a target cell-mediated depletion of SKW6.4 lymphoma cells (CD20+/CD19+/CD95+), while LX-1 cells (CD20−/CD19−/CD95+) were unaffected (Figure S2d). This evidence concerns the gene FAS and lymphoma.